325 related articles for article (PubMed ID: 16859791)
1. Brain dopamine and kinematics of graphomotor functions.
Lange KW; Mecklinger L; Walitza S; Becker G; Gerlach M; Naumann M; Tucha O
Hum Mov Sci; 2006 Oct; 25(4-5):492-509. PubMed ID: 16859791
[TBL] [Abstract][Full Text] [Related]
2. Attention and movement execution during handwriting.
Tucha O; Mecklinger L; Walitza S; Lange KW
Hum Mov Sci; 2006 Oct; 25(4-5):536-52. PubMed ID: 17011653
[TBL] [Abstract][Full Text] [Related]
3. The effect of caffeine on handwriting movements in skilled writers.
Tucha O; Walitza S; Mecklinger L; Stasik D; Sontag TA; Lange KW
Hum Mov Sci; 2006 Oct; 25(4-5):523-35. PubMed ID: 17010462
[TBL] [Abstract][Full Text] [Related]
4. Kinematic analysis of dopaminergic effects on skilled handwriting movements in Parkinson's disease.
Tucha O; Mecklinger L; Thome J; Reiter A; Alders GL; Sartor H; Naumann M; Lange KW
J Neural Transm (Vienna); 2006 May; 113(5):609-23. PubMed ID: 16082511
[TBL] [Abstract][Full Text] [Related]
5. Computational analysis of open loop handwriting movements in Parkinson's disease: a rapid method to detect dopamimetic effects.
Eichhorn TE; Gasser T; Mai N; Marquardt C; Arnold G; Schwarz J; Oertel WH
Mov Disord; 1996 May; 11(3):289-97. PubMed ID: 8723147
[TBL] [Abstract][Full Text] [Related]
6. Quantitative measurement of handwriting in the assessment of drug-induced parkinsonism.
Caligiuri MP; Teulings HL; Filoteo JV; Song D; Lohr JB
Hum Mov Sci; 2006 Oct; 25(4-5):510-22. PubMed ID: 16647772
[TBL] [Abstract][Full Text] [Related]
7. Handwriting in patients with Parkinson disease: effect of L-dopa and stimulation of the sub-thalamic nucleus on motor anticipation.
Bidet-Ildei C; Pollak P; Kandel S; Fraix V; Orliaguet JP
Hum Mov Sci; 2011 Aug; 30(4):783-91. PubMed ID: 21339012
[TBL] [Abstract][Full Text] [Related]
8. Surface electromyography shows increased mirroring in Parkinson's disease patients without overt mirror movements.
Cincotta M; Giovannelli F; Borgheresi A; Balestrieri F; Vanni P; Ragazzoni A; Zaccara G; Ziemann U
Mov Disord; 2006 Sep; 21(9):1461-5. PubMed ID: 16705686
[TBL] [Abstract][Full Text] [Related]
9. Impact of Parkinson's disease and dopaminergic medication on proprioceptive processing.
Mongeon D; Blanchet P; Messier J
Neuroscience; 2009 Jan; 158(2):426-40. PubMed ID: 18996173
[TBL] [Abstract][Full Text] [Related]
10. Levodopa enhances synaptic plasticity in the substantia nigra pars reticulata of Parkinson's disease patients.
Prescott IA; Dostrovsky JO; Moro E; Hodaie M; Lozano AM; Hutchison WD
Brain; 2009 Feb; 132(Pt 2):309-18. PubMed ID: 19050033
[TBL] [Abstract][Full Text] [Related]
11. Basal ganglia, dopamine and temporal processing: performance on three timing tasks on and off medication in Parkinson's disease.
Jones CR; Malone TJ; Dirnberger G; Edwards M; Jahanshahi M
Brain Cogn; 2008 Oct; 68(1):30-41. PubMed ID: 18378374
[TBL] [Abstract][Full Text] [Related]
12. An effect of dopamine depletion on decision-making: the temporal coupling of deliberation and execution.
Pessiglione M; Czernecki V; Pillon B; Dubois B; Schüpbach M; Agid Y; Tremblay L
J Cogn Neurosci; 2005 Dec; 17(12):1886-96. PubMed ID: 16356326
[TBL] [Abstract][Full Text] [Related]
13. Dopaminergic modulation of cognitive interference after pharmacological washout in Parkinson's disease.
Fera F; Nicoletti G; Cerasa A; Romeo N; Gallo O; Gioia MC; Arabia G; Pugliese P; Zappia M; Quattrone A
Brain Res Bull; 2007 Sep; 74(1-3):75-83. PubMed ID: 17683792
[TBL] [Abstract][Full Text] [Related]
14. Kinematic characteristics of bidirectional delta-lognormal primitives in young and older subjects.
Woch A; Plamondon R; O'Reilly C
Hum Mov Sci; 2011 Feb; 30(1):1-17. PubMed ID: 21227521
[TBL] [Abstract][Full Text] [Related]
15. Levodopa-sensitive, dynamic changes in effective connectivity during simultaneous movements in Parkinson's disease.
Palmer SJ; Eigenraam L; Hoque T; McCaig RG; Troiano A; McKeown MJ
Neuroscience; 2009 Jan; 158(2):693-704. PubMed ID: 18722512
[TBL] [Abstract][Full Text] [Related]
16. The influence of dopamine on semantic activation in Parkinson's disease: evidence from a multipriming task.
Angwin AJ; Copland DA; Chenery HJ; Murdoch BE; Silburn PA
Neuropsychology; 2006 May; 20(3):299-306. PubMed ID: 16719623
[TBL] [Abstract][Full Text] [Related]
17. How to assess motor impairment in writer's cramp.
Zeuner KE; Peller M; Knutzen A; Holler I; Münchau A; Hallett M; Deuschl G; Siebner HR
Mov Disord; 2007 Jun; 22(8):1102-9. PubMed ID: 17230462
[TBL] [Abstract][Full Text] [Related]
18. Antiparkinson medications improve agonist activation but not antagonist inhibition during sequential reaching movements.
Kelly VE; Bastian AJ
Mov Disord; 2005 Jun; 20(6):694-704. PubMed ID: 15719427
[TBL] [Abstract][Full Text] [Related]
19. Levodopa improves time-based prospective memory in Parkinson's disease.
Costa A; Peppe A; Brusa L; Caltagirone C; Gatto I; Carlesimo GA
J Int Neuropsychol Soc; 2008 Jul; 14(4):601-10. PubMed ID: 18577289
[TBL] [Abstract][Full Text] [Related]
20. Action naming in Parkinson's disease patients on/off dopamine.
Herrera E; Cuetos F
Neurosci Lett; 2012 Apr; 513(2):219-22. PubMed ID: 22387157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
